From Medscape Dermatology

European Academy of Dermatology and Venereology (EADV) 2023 Congress

October 11 - 14, 2023; Berlin, Germany

October 11 - 14, 2023 Berlin, Germany

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News From EADV 2022

Hope Shines Bright for Hidradenitis Suppurativa Treatments Secukinumab and the investigational drug brepocitinib were shown to alleviate the effects of the chronic and painful skin condition in separate, unrelated trials.
Medscape Medical News, Sep 16, 2022
Study Identifies Skin Biomarkers That Predict Newborn Eczema Risk During the first 2 months of life, changes in skin biomarkers were predictive of whether children would develop atopic dermatitis up to 2 years later.
Medscape Medical News, Sep 28, 2022
Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria Both doses of ligelizumab evaluated met the primary endpoint of superiority to placebo for a complete response at 16 weeks of therapy.
Medscape Medical News, Sep 15, 2022

Previous Coverage

Related Resources